长春高新(000661.SZ)控股子公司黄体酮注射液(II)获得药品注册证书

智通财经06-25

智通财经APP讯，长春高新(000661.SZ)公告，公司控股子公司长春金赛药业有限责任公司收到国家药品监督管理局核准签发的《药品注册证书》，现将相关审批结论公告如下：“根据《中华人民共和国药品管理法》及有关规定，经审查，黄体酮注射液(II)1.112ml:25mg符合药品注册的有关要求，批准注册，发给药品注册证书。”批准的适应症为：“用于辅助生殖技术(ART)中黄体酮的补充治疗，适用于不能使用或...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2446101038?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-06-25 20:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2446101038","market":"hk","top_or_hot":-1,"title":"长春高新(000661.SZ)控股子公司黄体酮注射液(II)获得药品注册证书","media":"智通财经","content":"<div>\n<p>智通财经APP讯，长春高新(000661.SZ)公告，公司控股子公司长春金赛药业有限责任公司收到国家药品监督管理局核准签发的《药品注册证书》，现将相关审批结论公告如下：“根据《中华人民共和国药品管理法》及有关规定，经审查，黄体酮注射液(II)1.112ml:25mg符合药品注册的有关要求，批准注册，发给药品注册证书。”批准的适应症为：“用于辅助生殖技术(ART)中黄体酮的补充治疗，适用于不能使用或...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1140370.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>长春高新(000661.SZ)控股子公司黄体酮注射液(II)获得药品注册证书</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n长春高新(000661.SZ)控股子公司黄体酮注射液(II)获得药品注册证书\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-25 20:21 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1140370.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，长春高新(000661.SZ)公告，公司控股子公司长春金赛药业有限责任公司收到国家药品监督管理局核准签发的《药品注册证书》，现将相关审批结论公告如下：“根据《中华人民共和国药品管理法》及有关规定，经审查，黄体酮注射液(II)1.112ml:25mg符合药品注册的有关要求，批准注册，发给药品注册证书。”批准的适应症为：“用于辅助生殖技术(ART)中黄体酮的补充治疗，适用于不能使用或...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1140370.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0046","symbol_name":"生物疫苗","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1140370.html","article_id":"2446101038","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2446101038","pubTimestamp":1719318063,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，长春高新(000661.SZ)公告，公司控股子公司长春金赛药业有限责任公司收到国家药品监督管理局核准签发的《药品注册证书》，现将相关审批结论公告如下：“根据《中华人民共和国药品管理法》及有关规定，经审查，黄体酮注射液(II)1.112ml:25mg符合药品注册的有关要求，批准注册，发给药品注册证书。”批准的适应症为：“用于辅助生殖技术(ART)中黄体酮的补充治疗，适用于不能使用或不能耐受阴道制剂的女性”。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK0046":"生物疫苗","BK0075":"新三板","BK0239":"医药制造","BK0188":"融资融券","000661":"长春高新","BK0057":"长吉图板块","BK0028":"国家队"},"translate_title":"Progesterone Injection (II), a holding subsidiary of Changchun High-tech (000661. SZ), obtained the drug registration certificate","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000661":1},"content_text":"智通财经APP讯，长春高新(000661.SZ)公告，公司控股子公司长春金赛药业有限责任公司收到国家药品监督管理局核准签发的《药品注册证书》，现将相关审批结论公告如下：“根据《中华人民共和国药品管理法》及有关规定，经审查，黄体酮注射液(II)1.112ml:25mg符合药品注册的有关要求，批准注册，发给药品注册证书。”批准的适应症为：“用于辅助生殖技术(ART)中黄体酮的补充治疗，适用于不能使用或不能耐受阴道制剂的女性”。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2446101038"}